Text Size

Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00518700
First received: August 17, 2007
Last updated: April 21, 2008
Last verified: April 2008
History of Changes
  Purpose

To compare corneal staining after contact lens instillation with a new MPS vs. RepleniSH


Condition Intervention Phase
Corneal Staining
 Other: new MPS
Other: RepleniSH
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Investigator)

Resource links provided by NLM:

MedlinePlus related topics: Eye Wear
U.S. FDA Resources

Further study details as provided by Innovative Medical:

Enrollment: 24
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. CL patients using MPS products currently
  5. Patients using Contact Lenses habitually (at least 1 month)

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia.
  4. Current use of Restasis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00518700

Locations
United States, California
Private Practice
Azusa, California, United States, 91702
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Milton Hom, OD, FAAO Private Practice
  More Information

No publications provided

Responsible Party: Innovative medical, Innovative Medical
ClinicalTrials.gov Identifier: NCT00518700     History of Changes
Other Study ID Numbers: 5321
Study First Received: August 17, 2007
Last Updated: April 21, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 21, 2013